159 related articles for article (PubMed ID: 8695968)
1. Bone mass and mineral metabolism in Klinefelter's syndrome.
Luisetto G; Mastrogiacomo I; Bonanni G; Pozzan G; Botteon S; Tizian L; Galuppo P
Osteoporos Int; 1995; 5(6):455-61. PubMed ID: 8695968
[TBL] [Abstract][Full Text] [Related]
2. Klinefelter's syndrome and bone mineral density: is osteoporosis a constant feature?
Hiéronimus S; Lussiez V; Le Duff F; Ferrari P; Bständig B; Fénichel P
Ann Endocrinol (Paris); 2011 Feb; 72(1):14-8. PubMed ID: 21126728
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density and bone markers in hypogonadotropic and hypergonadotropic hypogonadal men after prolonged testosterone treatment.
De Rosa M; Paesano L; Nuzzo V; Zarrilli S; Del Puente A; Oriente P; Lupoli G
J Endocrinol Invest; 2001 Apr; 24(4):246-52. PubMed ID: 11383911
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis and Klinefelter's syndrome.
Horowitz M; Wishart JM; O'Loughlin PD; Morris HA; Need AG; Nordin BE
Clin Endocrinol (Oxf); 1992 Jan; 36(1):113-8. PubMed ID: 1532769
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of bone mineral density and testosterone levels in Korean men with non-mosaic Klinefelter's syndrome.
Seo JT; Lee JS; Oh TH; Joo KJ
BJU Int; 2007 Jan; 99(1):141-6. PubMed ID: 17092285
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter's syndrome after long-term testosterone substitution.
van den Bergh JP; Hermus AR; Spruyt AI; Sweep CG; Corstens FH; Smals AG
Osteoporos Int; 2001; 12(1):55-62. PubMed ID: 11305084
[TBL] [Abstract][Full Text] [Related]
7. Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.
Ferlin A; Selice R; Di Mambro A; Ghezzi M; Di Nisio A; Caretta N; Foresta C
Osteoporos Int; 2015 Aug; 26(8):2193-202. PubMed ID: 25963234
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone.
Bojesen A; Birkebæk N; Kristensen K; Heickendorff L; Mosekilde L; Christiansen JS; Gravholt CH
Osteoporos Int; 2011 May; 22(5):1441-50. PubMed ID: 20658127
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of testosterone replacement therapy on bone in hypogonadal men with Klinefelter Syndrome.
Tahani N; Nieddu L; Prossomariti G; Spaziani M; Granato S; Carlomagno F; Anzuini A; Lenzi A; Radicioni AF; Romagnoli E
Endocrine; 2018 Aug; 61(2):327-335. PubMed ID: 29696556
[TBL] [Abstract][Full Text] [Related]
10. Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis.
Pizzocaro A; Vena W; Condorelli R; Radicioni A; Rastrelli G; Pasquali D; Selice R; Ferlin A; Foresta C; Jannini EA; Maggi M; Lenzi A; Pivonello R; Isidori AM; Garolla A; Francavilla S; Corona G;
J Endocrinol Invest; 2020 Dec; 43(12):1675-1687. PubMed ID: 32567016
[TBL] [Abstract][Full Text] [Related]
11. Loss of bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement.
Wong FH; Pun KK; Wang C
Osteoporos Int; 1993 Jan; 3(1):3-7. PubMed ID: 8422513
[TBL] [Abstract][Full Text] [Related]
12. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
[TBL] [Abstract][Full Text] [Related]
13. Decreased nocturnal melatonin secretion in patients with Klinefelter's syndrome.
Luboshitzky R; Wagner O; Lavi S; Herer P; Lavie P
Clin Endocrinol (Oxf); 1996 Dec; 45(6):749-54. PubMed ID: 9039342
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.
Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
Calcif Tissue Int; 1997 Feb; 60(2):148-54. PubMed ID: 9056162
[TBL] [Abstract][Full Text] [Related]
15. Gonadal status is an important determinant of bone density in acromegaly.
Lesse GP; Fraser WD; Farquharson R; Hipkin L; Vora JP
Clin Endocrinol (Oxf); 1998 Jan; 48(1):59-65. PubMed ID: 9509069
[TBL] [Abstract][Full Text] [Related]
16. The effect of testosterone treatment on bone mineral density in Klinefelter syndrome: A retrospective cohort study.
Willems S; David K; Decallonne B; Marcq P; Antonio L; Vanderschueren D
Andrology; 2023 Oct; 11(7):1295-1302. PubMed ID: 36792918
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women.
Filip R; Raszewski G
Clin Endocrinol (Oxf); 2009 Feb; 70(2):214-20. PubMed ID: 18547340
[TBL] [Abstract][Full Text] [Related]
18. Low INSL3 in Klinefelter syndrome is related to osteocalcin, testosterone treatment and body composition, as well as measures of the hypothalamic-pituitary-gonadal axis.
Overvad S; Bay K; Bojesen A; Gravholt CH
Andrology; 2014 May; 2(3):421-7. PubMed ID: 24659579
[TBL] [Abstract][Full Text] [Related]
19. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
[TBL] [Abstract][Full Text] [Related]
20. Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: results of a double-blind placebo-controlled study with open follow-up.
Finkenstedt G; Gasser RW; Höfle G; Watfah C; Fridrich L
Eur J Endocrinol; 1997 Mar; 136(3):282-9. PubMed ID: 9100553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
